Simple once-daily treatment
Not a steroid. No boxed warning
ZORYVE Foam & Cream:

DESIGNED WITH
PURPOSE AND THE
PATIENT IN MIND1,2

PATIENT-FRIENDLY
FOAM AND CREAM 
FORMULATIONS
Formulated for all skin and hair types
  • Spreads easily, absorbs quickly, non-greasy
  • Simple application anywhere on the body, including difficult-to-treat scalp and other hair‑bearing areas1,2
Moisturizing properties1-5
  • Novel, water-based emollient formulation
No known sensitizers or irritants1,2
  • No fragrances, ethanol, or propylene glycol
Drug delivery without disrupting the skin barrier1,2,4-6
  • No ceramide-stripping properties
Simple once-daily treatment
ZORYVE (roflumilast) Cream 0.3%, ZORYVE (roflumilast) Cream 0.15%, and ZORYVE (roflumilast) Topical Foam 0.3%
ZORYVE (roflumilast) cream 0.3%

Plaque
Psoriasis

Cream 0.3%
For age 6+

ZORYVE (roflumilast) cream 0.15%

Mild to Moderate
Atopic Dermatitis

Cream 0.15%
For age 6+

ZORYVE (roflumilast) Topical Foam 0.3%

Seborrheic
Dermatitis

Foam 0.3%
For age 9+

Plaque
Psoriasis

Foam 0.3%
For age 12+

The only prescription topical WITHOUT PENETRATION ENHANCERS for plaque psoriasis, atopic dermatitis, and seborrheic dermatitis7*

*Penetration enhancers include propylene glycol (PG), dimethyl sulfoxide (DMSO), ethanol above 10% w/w, isopropyl myristate (IPM), sodium laureth sulfate (SLS), and in some cases butylhydroxytoluene (E321) or diethylene glycol monoethyl ether.

ZORYVE is for topical use only and not
for ophthalmic, oral, or intravaginal use.

Request a Representative

Find Patient Access Support